Anxo Vidal

Background

About Anxo Vidal

Anxo Vidal received his Ph.D. in Cell Biology in 1997 at the University of Santiago de Compostela. From 1998 to 2003 he was a postdoc in the Laboratory of Cell Cycle Regulation at Memorial Sloan-Kettering Cancer Center. During this period, under the supervision of Dr Andrew Koff, Anxo's research interests were focused in the study of p27Kip1 regulation (a cell cycle inhibitor and a tumor suppressor), and in the genetic and functional relationships among tumor suppressors. In 2002 Anxo was ranked no. 2 nationwide in the area of Physiology in the "Ramon y Cajal" Program launched by the Spanish Government. Back in Santiago de Compostela in 2003, he established his own laboratory devoted to study cell cycle inhibitors and tumor suppressor biology through mouse models and functional genomics approaches. Since 2008, Anxo is an Associate Professor of Physiology in the University of Santiago de Compostela. Anxo was involved in the characterization of 'cis' elements on p27 mRNA important for its translation, the isolation of proteins that bind those sites as well as the delineation of signalling pathways involved (Millard et al MCB Vidal et al JBC 2002). Using genetically-modified mouse models his work has contributed to discover new cooperative functions of cell cycle regulators in angiogenesis (Vidal et al, PNAS 2005), endochondral bone formation (Yeh et al, MCB 2007), viral infection (Garcia et al PLOS One 2009), as well as in food intake and metabolism (Velasquez et al Diabetes 2011). He was the recipient of the 2006 Novartis Award in Endocrine Tumor Pathology. Invited speaker at several national and foreign research centers. He is an author of some 20 international publications in high impact journals (PNAS, EMBO J, JACS.). Principal investigator of competitive national and international grants, he has also participate in research consortia and in a European project about metastatic cancer treatment.